
Loading page…
The Smear for Malarial Parasite (MP) test is the gold-standard diagnostic test for malaria — a microscopic examination of both thick and thin blood films stained with Giemsa stain to detect and identify Plasmodium parasites inside red blood cells. The thick film concentrates red cells for high sensitivity in detecting low-level parasitaemia, while the thin film preserves cell morphology for accurate species identification and parasite density estimation. This test is the definitive investigation for suspected malaria and guides species-specific treatment. No fasting required.
Key benefits of this package include:
What Does the Smear for Malarial Parasite (MP) Test Measure?
| Level / Result | Possible Interpretation |
|---|---|
| No parasites detected (Negative) | No malaria parasites found on this smear — does not exclude malaria if clinical suspicion is high; repeat smear or RDT recommended |
| P. falciparum detected | Potentially dangerous malaria — requires urgent treatment; assess for severe malaria features |
| P. vivax detected | Most common malaria in India — responds to chloroquine + primaquine; check G6PD before primaquine |
| P. malariae detected | Quartan malaria — benign course; chloroquine treatment; may persist asymptomatically for years |
| Mixed infection detected | P. falciparum + P. vivax co-infection — treat as falciparum; add primaquine for vivax |
| Low density parasitaemia (< 0.1%) | Early infection or partially treated malaria — clinical symptoms may be significant despite low count |
| High density parasitaemia (> 5% with P. falciparum) | Severe falciparum malaria — urgent hospitalisation and IV artesunate required |
Important Note: A single negative malaria smear does not exclude malaria if clinical suspicion remains high — parasite density varies with the fever cycle and may be too low to detect on one smear. Standard practice is three smears at 12–24 hour intervals before malaria is excluded. In cases where smear expertise is limited, Rapid Diagnostic Tests (RDTs) complement microscopy. All positive results require immediate physician review for treatment initiation.
Why Species Identification Matters for Treatment: P. falciparum and P. vivax require different treatment regimens. P. falciparum is treated with Artemisinin-based Combination Therapy (ACT — artemether-lumefantrine or artesunate-mefloquine); P. vivax with chloroquine (where sensitive) plus primaquine to clear liver-stage hypnozoites that cause relapse. Before giving primaquine, G6PD (Glucose-6-Phosphate Dehydrogenase) status must be checked — primaquine causes life-threatening haemolysis in G6PD-deficient individuals. Species identification on the smear directly determines this treatment pathway.

Book once, we handle the rest. Our certified phlebotomist arrives at your doorstep — your report is delivered within 24 hours.
Trusted by millions of Customers across South India — these are the tests our doctors recommend most.